JDRF funding opportunities

We offer a wide variety of grants and fellowships for qualified researchers in the field of type 1 diabetes and its associated complications. We are currently looking for grant applications in all of the areas listed below.

Requests for applications

(* all dates in dd/mm/yyyy format)

 

Community Innovation opportunities – Request for Applications (RFA) details Application opens* Application deadline Award notification Earliest start date
JDRF Impact Grants, Download application form Passed Passed Passed 01/11/2019

 

Targeted opportunities – Request for Applications (RFA) details Expression of Interest deadline* Expression of Interest outcome Full Application deadline Earliest Award notification Earliest start date
Behavioural Health and Psychology
Telehealth in Type 1 Diabetes behavioral Health and Psychology Passed Passed Passed 01/03/2020 01/05/2020
Beta Cell Replacement Therapies
3D Bioprinting and Biofabrication of Rationally designed engineered tissue constructs as therapeutic products for treatment of Type 1 Diabetes Passed Passed Passed 30/04/2020 30/06/2020
Beta Cell Replacement Innovative Awards N/A N/A Passed 31/01/2020 01/03/2020
Beta Cell Regeneration and Survival
Discovery and Development of strategies for targeted drug delivery to human islets for T1D 07/02/2020 21/02/2020 20/03/2020 31/07/2020 01/09/2020
Alpha Cell Function
Not currently open
Artificial Pancreas
Not currently open
Complications
Novel Therapeutic Strategies to Prevent or Delay Progression of Early Stage Diabetic Nephropathy Passed Passed Passed 31/07/2020 30/09/2020
Novel Therapeutic Strategies to Prevent or Delay Progression or Early Stage Diabetic Retinopathy Passed Passed Passed 31/05/2020 31/07/2020
Metabolic Control
Metabolic Control Innovative Awards N/A N/A Passed 31/01/2020 01/03/2020
Repositioning Drugs to Improve Metabolic Control in Established Type 1 Diabetes Passed Passed Passed 31/03/2020 01/07/2020
Safe and Effective Use of SGLT Inhibitors for Type 1 Diabetes Passed Passed Passed 31/05/2020 31/08/2020
Immunotherapies
Immunotherapies Innovative Awards N/A N/A Passed 31/01/2020 01/03/2020
Validation of T Cell Biomarkers and Assays for T1D Passed Passed Passed 28/02/2020 01/04/2020
Therapeutic Development and Clinical Testing of Immune Therapies for Type 1 Diabetes Passed Passed Passed 31/03/2020 01/05/2020
Decoding Immune Mediated Diseases – Novel Approaches for Therapeutic Insights Passed Passed Passed 31/05/2020 01/08/2020
Neoepitoptes in type 1 diabetes: Pathogenesis, staging, and therapeutic utility Passed Passed Passed Passed 01/01/2020
Prevention
The Role of the Microbiome in Type 1 Diabetes: Pathogenesis and Therapeutic Utility Passed Passed Passed 30/04/2020 01/07/2020
Optimisation and Clinical Validation of Islet Autoantibody Assays for Screening for Type 1 Diabetes Risk For Industry (IDDP) only Passed For Academia (SRA) Passed 03/01/2020 01/03/2020
TrialNet
 Not currently open
Pilot Studies
Not currently open

 

Annual opportunities – Request for Applications (RFA) details Application opens* Application deadline Award notification Earliest start date
Postdoctoral Fellowships 01/05/2019 02/07/2019 31/01/2020 01/03/2020
Advanced Postdoctoral Fellowships 01/05/2019 02/07/2019 31/01/2020 01/03/2020
Career Development Awards 01/05/2019 02/07/2019 31/01/2020 01/03/2020
Early Career Patient-Oriented Diabetes Research Awards 01/05/2019 02/07/2019 31/01/2020 01/03/2020
Ongoing opportunities – Request for Applications (RFA) details Application opens* Letter of Intent (LOI) deadline LOI Status Notification Earliest start date
Strategic Research Agreements† N/A 01/08/2019† 16/09/2019 N/A
N/A 04/11/2019† 20/12/2019 N/A
N/A 03/02/2020† 19/03/2020 N/A
Industry Discovery & Development Partnerships Contact  the Scientific Lead for the program in which your project fits.
Conference Grants Submit application to the appropriate Therapeutic Area Program Director, 3-6 months prior to meeting date

All other grant mechanisms

† The SRA mechanism includes Project Concepts, which allow for unsolicited proposals outside of the more focused RFA opportunities. Applications are reviewed on a rolling basis.